Andilab, Meryll Faith .

HRN: 28-63-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
AMPICILLIN 1GM (VIAL)
03/11/2026
03/12/2026
IVT
2g
Q6
Prom
Remove - Pending Acceptance
03/13/2026
METRONIDAZOLE 500MG (TAB)
03/13/2026
03/19/2026
PO
500mg
Q8
CS
Checking Initial Appropriateness 
03/13/2026
CO-AMOXICLAV 625MG (TAB)
03/13/2026
03/19/2026
PO
1tab
Q8
Ltcs
Checking Initial Appropriateness 
03/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/13/2026
03/14/2026
IV
500mg
Q8
Cs
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: